Trademark: 79363341
Word
MAMMATYPER
Status Date
Tuesday, June 4, 2024
Registration Number
7404160
Registration Date
Tuesday, June 4, 2024
Filing Date
Monday, November 7, 2022
Published for Opposition
Tuesday, March 19, 2024
5 Diagnostic preparations for medical purposes relating to obstetrics or breast cancer; chemical reagents for medical purposes relating to obstetrics or breast cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical drugs for the treatment of breast cancer; pharmaceutical preparations for the prevention and treatment of breast cancer; pharmaceutical products for the prevention and treatment of breast cancer; biological preparations for the treatment of breast cancer
44 Genetic testing for medical use; genetic testing for medical purposes; telemedicine services on medical testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening relating to obstetrics and breast cancer; rental of medical equipment, namely, equipment relating to obstetrics and breast cancer; medical therapy services in the fields of obstetrics and breast cancer; medical analysis services for the diagnosis of breast cancer; provide breast cancer screening services
10 Testing apparatus for medical purposes relating to obstetrics and breast cancer for detecting cancer; genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes relating to obstetrics and breast cancer; apparatus for use in medical analysis relating to obstetrics or breast cancer for detecting cancer; medical apparatus and instruments relating to obstetrics and breast cancer; apparatus for DNA and RNA testing for medical purposes, namely, X-ray diagnostic apparatus
42 Scientific research in the fields of obstetrics and breast cancer; scientific research on breast cancer for medical purposes; scientific research in the nature of conducting clinical trials for others in the fields of obstetrics and breast cancer; medical research in the fields of obstetrics and breast cancer; structural and functional analysis of genomes; research and development of pharmaceuticals of breast cancer; medical research in oncology, namely, breast cancer; genetic testing for scientific research; technological research in the fields of obstetrics and breast cancer
Mar 4, 2023
Application Filing Receipt Mailed
Feb 23, 2023
Sn Assigned For Sect 66a Appl From Ib
Feb 27, 2023
Limitation From Original Application Entered
Feb 28, 2023
New Application Office Supplied Data Entered
Mar 25, 2023
New Representative At Ib Received
May 27, 2023
Assigned To Examiner
Jun 5, 2023
Non-Final Action Written
Jun 6, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jul 13, 2023
Refusal Processed By Mpu
Jul 13, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 1, 2023
Refusal Processed By Ib
Sep 16, 2023
Correction Transaction Received From Ib
Oct 30, 2023
Correction From Ib Entered - Attorney Review Required
Oct 31, 2023
Attorney Review Completed
Jan 12, 2024
Teas Response To Office Action Received
Jan 12, 2024
Correspondence Received In Law Office
Jan 12, 2024
Teas/Email Correspondence Entered
Feb 15, 2024
Approved For Pub - Principal Register
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Mar 19, 2024
Published For Opposition
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 4, 2024
Registered-Principal Register
Jun 4, 2024
Notice Of Registration Confirmation Emailed
Sep 4, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
